Tiziana Life Other Current Liab Over Time
| TLSA Stock | USD 0.94 0.04 4.07% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Tiziana Life Performance and Tiziana Life Correlation. Tiziana |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Tiziana Life. If investors know Tiziana will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Tiziana Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.13) | Revenue Per Share (0.02) | Return On Assets (0.70) | Return On Equity (1.81) |
The market value of Tiziana Life Sciences is measured differently than its book value, which is the value of Tiziana that is recorded on the company's balance sheet. Investors also form their own opinion of Tiziana Life's value that differs from its market value or its book value, called intrinsic value, which is Tiziana Life's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Tiziana Life's market value can be influenced by many factors that don't directly affect Tiziana Life's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Tiziana Life's value and its price as these two are different measures arrived at by different means. Investors typically determine if Tiziana Life is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Tiziana Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Other Current Liab Analysis
Compare Tiziana Life Sciences and related stocks such as Clearmind Medicine Common, Hillstream Biopharma, and Coeptis Therapeutics Other Current Liab Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CMND | 64.7 K | 64.7 K | 64.7 K | 64.7 K | 64.7 K | 64.7 K | 64.7 K | 31.8 K | 31.8 K | 6.1 K | 6.7 K | 1.6 M | 3.2 M | 3.6 M | 3.8 M |
| COEP | 500 K | 500 K | 500 K | 500 K | 500 K | 500 K | 500 K | 500 K | 500 K | 500 K | 732.1 K | 199.1 K | 182 K | 532 K | 343.2 K |
| QNRX | 891.7 K | 891.7 K | 891.7 K | 891.7 K | 891.7 K | 891.7 K | 891.7 K | 891.7 K | 891.7 K | 891.7 K | 6.6 M | (740.4 M) | 2.8 M | 3 M | 3.1 M |
| AFMD | 422 K | 422 K | 422 K | 6.2 M | 3.8 M | 7.8 M | 892 K | 1 M | 24.3 M | 517 K | 58.5 M | 46.2 M | 46.2 M | 53.1 M | 55.8 M |
| LPTX | 1.2 M | 1.2 M | 1.2 M | 876 K | 2.4 M | (2.3 M) | 2.7 M | 3.5 M | 2.9 M | 3.4 M | 3 M | 4.9 M | 4.7 M | 5.7 M | 3 M |
| ADAP | 3.5 M | 3.5 M | 513.8 K | 52.1 M | 3.9 M | 3.9 M | 1.1 M | 27.2 M | 20.4 M | 23.4 M | 24.3 M | 27.6 M | 30.8 M | 23.5 M | 20.5 M |
| CRVS | 2.6 M | 2.6 M | 2.6 M | 2.6 M | 2.6 M | 1.5 M | 5.4 M | 6.5 M | 5.9 M | 6.9 M | 7.6 M | 7.1 M | 7.5 M | 2.6 M | 2.5 M |
| APTO | 653 K | 966.4 K | 1.4 M | 1.1 M | 1.2 M | 1.3 M | 1.3 M | 1.8 M | 1.5 M | 3.1 M | 3.6 M | 6 M | 5.7 M | 8.8 M | 9.3 M |
| BNOX | 22.2 K | 1.7 M | 2.1 M | 2.6 M | 4.2 M | 6.5 M | 9.2 M | 7.2 M | 2.8 M | 4.8 M | 866.2 K | 1.1 M | 1.2 M | 158.5 K | 150.6 K |
| SPRC | 522.9 K | 522.9 K | 522.9 K | 522.9 K | 261.4 K | 399.9 K | 592.2 K | 778 K | 277 K | 7 K | 666 K | 830 K | 3.8 M | 1.3 M | 942 K |
| BHVN | 4.7 M | 4.7 M | 4.7 M | 4.7 M | 4.7 M | 4.7 M | 4.7 M | 4.7 M | 8.8 M | 52.1 M | 27.1 M | 37.2 M | 38.1 M | 36.5 M | 32.1 M |
| IMNM | 476 K | 476 K | 476 K | 476 K | 476 K | 476 K | 476 K | 476 K | 476 K | 666 K | 1.4 M | 6.3 M | 4.7 M | 7.7 M | 3.9 M |
| INBX | 90 K | 90 K | 90 K | 90 K | 90 K | 90 K | 90 K | 372 K | 2.1 M | 4.8 M | 13.4 M | 9.6 M | 17.2 M | 43.9 M | 46.1 M |
Tiziana Life Sciences and related stocks such as Clearmind Medicine Common, Hillstream Biopharma, and Coeptis Therapeutics Other Current Liab description
My Equities
My Current Equities and Potential Positions
| Tiziana Life Sciences | TLSA |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Location | United Kingdom |
| Exchange | NASDAQ Exchange |
USD 0.9401
Check out Tiziana Life Performance and Tiziana Life Correlation. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Tiziana Life technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.